These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12825562)

  • 1. Noninstitutional commercial review boards in North America: a critical appraisal and comparison with IRBs.
    Lemmens T; Thompson A
    IRB; 2001; 23(2):1-12. PubMed ID: 12825562
    [No Abstract]   [Full Text] [Related]  

  • 2. The noninstitutional review board: what distinguishes us from them?
    Heath E
    IRB; 1998; 20(5):8-11. PubMed ID: 11657585
    [No Abstract]   [Full Text] [Related]  

  • 3. What IRBs could learn from corporate boards.
    Saver RS
    IRB; 2005; 27(5):1-6. PubMed ID: 16425474
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 5. Composition and operation of selected research ethics review committees in Latin America.
    Rivera R; Ezcurra E
    IRB; 2001; 23(5):9-12. PubMed ID: 12737173
    [No Abstract]   [Full Text] [Related]  

  • 6. Financial conflicts of interest and protection of human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
    [No Abstract]   [Full Text] [Related]  

  • 7. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 8. What do IRBs look like? What kind of support do they receive?
    De Vries RG; Forsberg CP
    Account Res; 2002; 9(3-4):199-216. PubMed ID: 12816128
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative analysis of research ethics review mechanisms and the ICH good clinical practice guideline.
    Hirtle M; Lemmens T; Sprumont D
    Eur J Health Law; 2000 Sep; 7(3):265-292. PubMed ID: 12174854
    [No Abstract]   [Full Text] [Related]  

  • 10. IRBs and financial conflicts of interest.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):5. PubMed ID: 12374180
    [No Abstract]   [Full Text] [Related]  

  • 11. Theoretical shortcomings of Institutional Review Boards and possible solutions.
    Yaghoobi M
    Arch Iran Med; 2011 May; 14(3):202-3. PubMed ID: 21529111
    [No Abstract]   [Full Text] [Related]  

  • 12. Research ethics boards--operational issues II.
    Maire A
    NCEHR Commun; 1999; 9(2):14-6. PubMed ID: 15540382
    [No Abstract]   [Full Text] [Related]  

  • 13. Overseeing research on therapeutic cloning: a private ethics board responds to its critics.
    Green RM; DeVries KO; Bernstein J; Goodman KW; Kaufmann R; Kiessling AA; Levin SR; Moss SL; Tauer CA
    Hastings Cent Rep; 2002; 32(3):27-33. PubMed ID: 12085512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research ethics boards--operational issues I.
    Lynch A
    NCEHR Commun; 1999; 9(2):9-14. PubMed ID: 15540381
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of health research participants in the United States: a review of two cases.
    Douglass A; Crampton P
    N Z Bioeth J; 2004 Jun; 5(2):6-12. PubMed ID: 15597497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for effectiveness: the functioning of Connecticut Clinical Ethics Committees.
    Berchelmann K; Blechner B
    J Clin Ethics; 2002; 13(2):131-45. PubMed ID: 12448188
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putting the "ethics" into "research ethics".
    Spike J
    Am J Bioeth; 2005; 5(1):51-3; author reply W15-8. PubMed ID: 16036663
    [No Abstract]   [Full Text] [Related]  

  • 19. Determining the level of statistician participation on Canadian-based research ethics boards.
    Thabane L; Childs A; Lafontaine A
    IRB; 2005; 27(2):11-4. PubMed ID: 15948326
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
    Beh HG
    Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.